Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
2 Mga view
administrator
08/04/23
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Magpakita ng higit pa
Mga Komento sa Facebook
Walang nakitang komento